// App-Quantinova.ai

4569 : Use of ACPD and ICA-1 as inhibitors of atypical proteinkinase C-zeta () and iota () in metastasized melanoma cells

Researchers

Presenter

  • Wishrawana S. Ratnayake

Principal Investigators

  • Mildred Acevedo-Duncan

Medical Centers

  • University of South Florida, Tampa, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Diabetes

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • ICA-1

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved